Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine infiltration for pain control after PCNL
NCT04160936Completed
- Start
- Feb 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in postoperative pain (2 arms). Primary endpoints: Visual Analogue Scale at 48 hours and Dynamic Visual Analogue Scale at 48 hours. Started Feb 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04160936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04160936.